Please login to the form below

Not currently logged in
Email:
Password:

Charles River ties up with Theorem for non-clinical testing

CROs form strategic alliance in bioanalysis, immunogenicity and immunology

Charles River Laboratories and Theorem Clinical Research have formed a strategic alliance to provide their clients with a new non-clinical testing and analysis service.

The US clinical research organisations' (CRO) alliance covers bioanalysis, immunogenicity and immunology programmes to support trials running all the way up to product registration.

Alan Bartlett, executive director of laboratory services, Charles River Laboratories: “We are pleased to partner with a world-class clinical trials organization like Theorem Clinical Research. Sponsors will benefit from the experience of both organisations. The alliance will offer a seamless transition from preclinical testing into the clinical arena.”

For Theorem the deal caps a busy few months that have seen it look to expand its network by signing a series of strategic alliances. Since July it has tied up with medical product development firm Ximedica, medical imaging company RadMD and regulatory consultancy the Emergo Group.

Article by
Dominic Tyer

17th September 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....